Medicine and Dentistry
Ovarian Cancer
100%
Angiotensin II
100%
Receptor Expression
100%
Tumor Angiogenesis
100%
Vasculotropin
80%
Angiotensin Receptor
60%
Angiogenic Factor
40%
Proliferating Cell Nuclear Antigen
40%
Microvessel
40%
In Vitro
20%
Tumor Cell
20%
Cancer Therapy
20%
Ovarian Cancer Cell Line
20%
Prognostic Factor
20%
Overall Survival
20%
Endothelial Cell
20%
Renin Angiotensin Aldosterone System
20%
Multivariate Analysis
20%
Secretion (Process)
20%
Progression Free Survival
20%
Cancer Tissue
20%
Cell Invasion
20%
Growth Promotor
20%
Keyphrases
Tumor Angiogenesis
100%
Patient Survival
100%
Receptor Expression
100%
Angiotensin II Type 1 Receptor (AT1R)
100%
Tumor Patients
100%
Ovarian Cancer
100%
Vascular Endothelial Growth Factor
25%
Angiogenic Factors
16%
Proliferating Cell nuclear Antigen
16%
Angiotensin II (Ang II)
16%
Microvessel Density
16%
Positive Staining
8%
Multivariate Analysis
8%
Endothelial Cells
8%
Histological Subtypes
8%
Growth Factors
8%
Ovarian Cancer Screening
8%
Overall Survival
8%
Novel Therapeutic Targets
8%
Progression-free Survival
8%
CD34
8%
Renin-angiotensin System
8%
Labeling Index
8%
Immunohistochemical Staining
8%
Vascular Endothelial Growth Factor Expression
8%
Independent Prognostic Factor
8%
CD34+ Cells
8%
Patient Outcomes
8%
Tumor Cell Invasion
8%
Ovarian Cancer Cells
8%
Clinical Potential
8%
Growth Factor Secretion
8%
Strongly Positive
8%
Ovarian Tissue
8%
Expression Intensity
8%
Intratumor
8%
FIGO Stage
8%
Negative Staining
8%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Neoplasm
100%
Angiotensin II
100%
Ovary Cancer
100%
Vasculotropin
66%
Angiotensin Receptor
50%
Angiogenic Factor
33%
Cycline
33%
Overall Survival
16%
Progression Free Survival
16%
Renin
16%
Angiotensin
16%
Molecular Target
16%
Growth Promotor
16%